Director, Real-World Evidence & Health Outcomes, mRNA Vaccines
Leads the integrated real-world evidence and health outcomes strategy for mRNA influenza vaccines, designing and interpreting US post-marketing vaccine effectiveness studies across late-stage development, launch and post-marketing phases. Partners with clinical development, epidemiology, medical affairs, regulatory, biostatistics and market access teams, and builds collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.